1. Home
  2. EVGO vs IMRX Comparison

EVGO vs IMRX Comparison

Compare EVGO & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGO

EVgo Inc.

HOLD

Current Price

$2.12

Market Cap

308.9M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.57

Market Cap

340.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGO
IMRX
Founded
2010
2008
Country
United States
United States
Employees
331
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.9M
340.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EVGO
IMRX
Price
$2.12
$5.57
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$5.23
$17.20
AVG Volume (30 Days)
4.6M
708.8K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.45
N/A
Revenue Next Year
$29.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$1.10
52 Week High
$5.18
$10.08

Technical Indicators

Market Signals
Indicator
EVGO
IMRX
Relative Strength Index (RSI) 55.12 54.39
Support Level $1.64 $5.34
Resistance Level $3.27 $5.80
Average True Range (ATR) 0.11 0.31
MACD 0.07 0.03
Stochastic Oscillator 97.06 70.00

Price Performance

Historical Comparison
EVGO
IMRX

About EVGO EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: